We recently compiled a list of the 12 Safest Stocks to Buy According to Hedge Funds. In this article, we are going to take a ...

Tectonic Therapeutic (TECX) plunges as Eli Lilly (LLY) ends a mid-stage trial for its kidney drug volenrelaxin which is similar to TECX's lead drug TX45. Read more here.

GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...

Could Eli Lilly’s Stock Struggles Reveal a Deeper Issue?

Dividend-screened portfolios of various kinds have failed to keep up with the broad US stock market over the past 10 years, ...

The leading Crohn's Disease companies such as Janssen, RedHill Biopharma, Amgen, Pfizer, Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene, AstraZeneca, Abbvie, Mesoblast, Alfasigma, ...

Wells Fargo lowered the firm’s price target on Eli Lilly (LLY) to $970 from $1,000 and keeps an Overweight rating on the shares. The firm ...

Citi analyst Geoff Meacham lowered the firm’s price target on Eli Lilly to $1,190 from $1,250 and keeps a Buy rating on the shares. Ahead of ...

Finding an employer that aligns with your values, work style, and career aspirations is more important than ever.

Shares of Netflix, Inc. (NASDAQ:NFLX – Get Free Report) traded down 0.5% on Monday after an insider sold shares in the company. The company traded as low as $965.00 and last traded at $972.77.

Financial writer bullish on Palantir Technologies Inc., raising target to $250/share due to AI growth and Trump ...

The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the ...